Baxter

A software issue in the Baxter Novum IQ Syringe Pump (Model 40800BAXUSL) may occur when you replace an empty syringe during a multi-syringe infusion while medication still needs to be delivered. This could affect the accuracy of drug delivery. Four loaner units have been identified and are affected.

A software problem in the Baxter Novum IQ Syringe Pump (Model 40800BAXUS) can occur when a syringe empties and is replaced during a multi-syringe infusion, potentially affecting the accuracy of medication delivery. The issue affects about 14,601 units distributed nationwide.

Baxter Healthcare is recalling one lot of Daptomycin in 0.9% Sodium Chloride Injection due to deviations from current good manufacturing practice (CGMP) standards during production. The affected lot (NC193856, expiring 04/18/2028) was distributed nationwide, Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling one lot of Vancomycin Injection (NDC 0338-3583-01, Lot #NC193894) due to deviations from good manufacturing practices (CGMP). The affected lot was distributed nationwide in the US, Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling three lots of Vasopressin injection due to manufacturing process deviations that do not meet FDA quality standards. The affected lots were distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling one lot of Clindamycin Injection USP in 5% Dextrose due to deviations from manufacturing quality standards. The affected lot was distributed nationwide, in Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling one lot of Clindamycin Injection USP in 5% Dextrose (900 mg/50 mL) due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling a specific lot of Clindamycin Phosphate in 0.9% Sodium Chloride Injection due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lot (NC193689, expiring 10/16/2027) was distributed nationwide, as well as to Puerto Rico and Chile.

Baxter Healthcare has recalled three specific lots of Clindamycin Injection USP (900 mg per 50 mL) due to deviations from Good Manufacturing Practice (CGMP) standards during production. The affected lots were distributed nationwide, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare has recalled multiple lots of Nexterone (amiodarone HCI) injection due to deviations from good manufacturing practices (CGMP) during production. The affected lots were distributed nationwide, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare has recalled specific lots of CARDENE IV (nicardipine hydrochloride) injection due to deviations from manufacturing quality standards. The affected lots were distributed in the United States, Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling one lot of Pantoprazole Sodium in 0.9% Sodium Chloride Injection due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed in the United States, Puerto Rico, and Chile.

Baxter Healthcare is recalling specific lots of Vasopressin injection due to deviations from manufacturing standards (CGMP). The affected lots may not meet required quality and purity standards. This is a precautionary recall of a medication used in hospitals and clinical settings.

Baxter Healthcare Corporation is recalling specific lots of dexmedetomidine hydrochloride injection due to deviations from current good manufacturing practice (CGMP) standards during production. The affected lots were distributed nationwide, in Puerto Rico, and Chile.

Baxter Healthcare is recalling two lots of famotidine injection (20 mg in 50 mL sodium chloride) due to deviations from manufacturing standards. The affected lots may not meet quality and sterility requirements.

Baxter Healthcare Corporation is recalling specific lots of Clindamycin Injection USP in 5% Dextrose due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lots are NC193764 (expiration 10/18/2027) and NC195232 (expiration 11/25/2027), distributed nationwide in the US, Puerto Rico, and Chile.

Baxter Healthcare is recalling one lot of Daptomycin in 0.9% Sodium Chloride Injection due to deviations from good manufacturing practices (CGMP) during production. The affected lot (NC188692, expiring 11/22/2027) was distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare is recalling specific lots of MYXREDLIN (insulin human injection) due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lots were distributed in the US, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling five lots of Vancomycin Injection USP in 5% Dextrose due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. The affected lots were distributed nationwide, in Puerto Rico, and Chile.

Baxter is recalling one lot of Anticoagulant Sodium Citrate Solution used with apheresis devices due to potential fiberglass particles in the solution. The affected product was distributed to one customer in the United States between July 2 and July 11, 2026. No adverse events have been reported to date.

Baxter is recalling two lots of 0.9% Sodium Chloride Injection (saline solution) used in hospitals and dialysis centers because fiberglass particles have been found in the solution. The affected lots were distributed to hospitals and medical suppliers in 14 states between July 31 and August 3, 2026. No injuries have been reported so far.

Baxter is recalling one lot of 70% Dextrose Injection used in hospitals and care facilities because stainless steel particles were found in the solution. If given intravenously, these particles could cause blood clots, block blood vessels, or damage organs. No patient injuries have been reported so far.

Baxter is recalling one lot of Cefazolin in Dextrose Injection (a frozen antibiotic infusion bag) because cardboard particles were found in the solution. The affected lot (LD175708, expiring February 14, 2027) was distributed between March and June 2025. No injuries have been reported so far.

The Adapter for Head Positioning (Model 1739994) used with Baxter operating tables may become loose during patient positioning and move unintentionally. This affects 13 units distributed worldwide, primarily in Minnesota, Maryland, Pennsylvania, Canada, and numerous other countries.

The nebulizer cup on Hillrom VOLARA System patient circuits may not lock properly during setup, allowing air and medication to leak during therapy. This leakage can reduce oxygen delivery to the patient and prevent medication from being administered as prescribed.

The nebulizer cup on Hillrom VOLARA System patient circuits may not lock properly during setup, causing air and medication to leak during therapy. This leakage can reduce oxygen levels and prevent medications from being delivered as prescribed.

The nebulizer cup on Hillrom Volara P.Circuit 5Kit devices can leak air and medication if not properly locked during setup. This leakage may reduce oxygen delivery to the patient and prevent the prescribed medication from being delivered effectively.

The nebulizer cup on Hillrom VOLARA System breathing circuits may not lock properly after medication is added, causing air and medication to leak during therapy. This leakage can reduce oxygen delivery to the patient and prevent the prescribed medication from being effectively inhaled.

Baxter Healthcare has issued an urgent correction for the Blue Ventilator Adapter Module used with the Volara Respiratory Therapy system in home care settings. Patients or caregivers may not be aware of risks including dangerously low oxygen levels or lung injury from improper device use.

The Welch Allyn Spot Vision Screener VS100 (software version 3.2.0.1) may display an unintended flickering screen due to a software issue. Flickering lights can trigger seizures in people who are photosensitive.